Poult enteritis and mortality syndrome (PEMS), a disease that affects turke
ys between 7 and 28 d of age, causes a severe inflammation of the intestina
l tract and is characterized in poults by severe diarrhea, high morbidity,
mortality, and stunting. The PEMS-associated mortality and growth depressio
n is related to malabsorption and decreased metabolic activity caused, in p
art, by a possible insulin deficiency or insensitivity. Insulin receptors a
re stimulated by the glucose tolerance factor (GTF) that incorporates Cr. B
ody Cr deficiency can be exacerbated by dietary deficiency and by increased
excretion due to stress associated with a diarrheal disease such as PEMS.
BioChrome(R) (BC) contains natural, preformed GTF, the bioactive form of Cr
. Experiments were conducted in which BC was blended into poult starter fee
d at 400 ppb during the first 21 d posthatch. Body weights were determined
at 1, 7, 14, and 21 d of age, and weekly feed conversions were calculated f
or each treatment group (control, BC, PEMS, and BC+PEMS). At 6 d posthatch,
each PEMS-designated poult was given a 0.1-mL oral gavage of a 10% suspens
ion of feces from PEMS-infected poults. Blood samples were taken via cardia
c puncture from four birds per treatment group at 7, 10, 14, 17, and 21 d o
f age. Radioimmunoassays were con ducted for plasma insulin, glucagon, thyr
oxine (T-4), and triiodothyronine (T-3) Plasma insulin levels were depresse
d in PEMS-infected poults from Days 10 through 17, but plasma glucagon leve
ls in the PEMS-infected poults were significantly elevated at 14 and 17 d,
after which they returned to control levels in both of the PEMS-infected gr
oups. The T-3 and T-4 levels were depressed through Day 21 in PEMS-infected
poults, but with BC treatment these blood hormone levels rebounded by Day
21. Body weights of PEMS-infected poults were increased significantly by th
e BC treatment but not to the level of noninfected controls.